Pharmaceutical manufacturing in Texas centers on the research, development, and production of medicines. Companies range from biotech startups to established firms, producing everything from generic medications to specialized therapeutics. Recent trends indicate a strong push towards innovative drug delivery methods and biologics manufacturing, especially as healthcare demands evolve. With a notable presence of contract development and manufacturing organizations, the industry signals robust growth due to new technologies and increasing investments, positioning Texas as a key player in the national and global pharmaceutical markets.

The following list features 23 pharmaceutical manufacturing companies located in Texas, highlighting a mix of small startups and mid-sized firms. Founded between 1938 and 2020, these companies are concentrated in cities like Houston, Fort Worth, and San Antonio. Specializations include radiopharmaceuticals, injectables, and contract services, ranging from active pharmaceutical ingredient production to innovative drug development. Most companies are privately owned, actively aiming for regulatory compliance while advancing their product offerings.

Continue reading to discover the top pharmaceutical manufacturing companies in Texas.

Top 23 Pharmaceutical Manufacturing Companies in Texas

1. Radiomedix, Inc.

• Website: radiomedix.com
• Ownership type: Private Equity
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series A, $40.0M, October 2022
• Founded year: 2006
• Headcount: 11-50
• LinkedIn: radiomedix-inc-

Radiomedix, Inc. is a clinical-stage biotechnology company based in Houston, Texas, founded in 2006. The company specializes in innovative targeted radiopharmaceuticals aimed at the diagnosis, monitoring, and treatment of cancer. Radiomedix operates across the entire spectrum of drug development, from initial discovery through to commercial scale manufacturing. They have established facilities that comply with regulatory standards, specifically 21 CFR 211, which are crucial for conducting clinical trials and producing radiopharmaceuticals for PET imaging and targeted therapies. Their services include drug discovery, pre-clinical evaluations, and full cGMP manufacturing capabilities. Recently, Radiomedix secured $40 million in Series A funding, highlighting their potential for growth and innovation in the pharmaceutical industry. The company is also involved in partnerships, such as a licensing agreement with Sanofi and Orano Med for next-generation radioligand medicine, further solidifying their position in the market.

2. Infallible Pharma

• Website: infalliblepharma.com
• Ownership type: Private
• Headquarters: Richmond, Texas, United States (USA)
• Employee distribution: India 100%
• Founded year: 2006
• Headcount: 1-10
• LinkedIn: infallible-pharma

Infallible Pharma, established in 2006 and based in Richmond, Texas, is a private pharmaceutical manufacturer that specializes in injectable drugs and healthcare products. The company primarily serves hospitals and healthcare institutions, ensuring the availability of high-quality medications that are crucial for patient care. With a strong commitment to quality and accessibility, Infallible Pharma aims to enhance healthcare delivery across various regions. The company has manufacturing units that are accredited by WHO-GMP, which underscores their dedication to maintaining high standards in production. Infallible Pharma is actively expanding its presence in international markets, targeting countries such as Cambodia, Kenya, Nigeria, Sri Lanka, and Yemen. Their product range includes a variety of pharmaceutical injections and infusions, particularly in the critical care segment. The company is also focused on obtaining international regulatory approvals to further its global reach. With a team of experienced professionals, Infallible Pharma is committed to improving patient outcomes through innovative healthcare solutions.

3. Sovereign Pharmaceuticals

• Website: sovpharm.com
• Ownership type: Private
• Headquarters: Fort Worth, Texas, United States (USA)
• Employee distribution: United States (USA) 87%, India 13%
• Founded year: 1990
• Headcount: 51-200
• LinkedIn: sovereign-pharmaceuticals

Sovereign Pharmaceuticals, based in Fort Worth, Texas, is a privately owned contract development and manufacturing organization (CDMO) that has been operational since 1990. The company specializes in the development and manufacturing of oral tablets, capsules, and liquid solutions, catering primarily to pharmaceutical companies that require reliable manufacturing services. Sovereign offers a comprehensive suite of services, including development, regulatory affairs, and quality assurance, ensuring that their products meet stringent industry standards. With a workforce of approximately 158 employees, the company operates a cGMP production facility and a dedicated R&D/QC facility, emphasizing their commitment to quality and compliance. Sovereign's expertise extends to the filing of ANDAs, INDs, and 505(b)(2) NDAs, showcasing their capability in navigating the regulatory landscape. Their facilities are equipped to handle a variety of dosage forms, making them a versatile partner in the pharmaceutical manufacturing sector.

4. Mission Pharmacal

• Website: missionpharmacal.com
• Ownership type: Corporate
• Headquarters: San Antonio, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: May 2019
• Founded year: 1946
• Headcount: 201-500
• LinkedIn: mission-pharmacal

Mission Pharmacal Company, based in San Antonio, Texas, has been a significant player in the pharmaceutical industry since its founding in 1946. The company is dedicated to improving health outcomes through the development and manufacturing of high-quality prescription and over-the-counter products. With a focus on women's health, urology, and dermatology, Mission Pharmacal addresses specific healthcare needs with innovative solutions. Their product offerings include a range of branded pharmaceuticals, generic alternatives, and contract development and manufacturing services. The company prides itself on using pure ingredients and state-of-the-art manufacturing methods, ensuring that their products meet the highest standards of quality. Mission Pharmacal's extensive experience and commitment to patient care position it as a noteworthy entity in the pharmaceutical manufacturing landscape.

5. QuVa Pharma, Inc.

• Website: quvapharma.com
• Ownership type: Private Equity
• Headquarters: Sugar Land, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Debt), $275.0M, May 2021
• Founded year: 2015
• Headcount: 1001-5000
• LinkedIn: quvapharma-inc-

QuVa Pharma, Inc., founded in 2015 and based in Sugar Land, Texas, specializes in 503B outsourcing services, focusing on the production of essential sterile injectable medications. The company plays a crucial role in supporting hospitals and healthcare systems by addressing drug shortages and enhancing operational efficiencies. QuVa Pharma operates through FDA-registered facilities, emphasizing compliance with regulatory standards and a commitment to quality. Their product offerings include a range of sterile injectables used in various medical fields, such as anesthesia, labor and delivery, and pain management. In 2021, QuVa Pharma secured $275 million in funding, which underscores investor confidence in their business model and growth potential. The company is dedicated to innovation, continuously developing new products to meet clinical needs and improve patient care outcomes.

6. GM Pharmaceuticals, Inc.

• Website: gmpharm.net
• Ownership type: Private
• Headquarters: Fort Worth, Texas, United States (USA)
• Employee distribution: United States (USA) 25%, Georgia 25%, India 25%, Other 25%
• Founded year: 1991
• Headcount: 11-50
• LinkedIn: gmpharm

GM Pharmaceuticals, Inc., founded in 1991 and based in Fort Worth, Texas, is a private pharmaceutical company that specializes in the development and sale of health products. The company primarily targets consumers, especially families, by offering effective and affordable solutions for common health issues, such as allergy relief and children's health. GM Pharmaceuticals has developed a range of products, including over-the-counter medications and homeopathic solutions, with a focus on quality and innovation. The company boasts over 100 patents, reflecting its commitment to creating unique formulations. With a workforce of approximately 22 employees, GM Pharmaceuticals operates in a niche market, providing products like TexaClear® and PediaClear® that address specific health needs. Their emphasis on safety and effectiveness positions them as a relevant player in the pharmaceutical sector.

7. Orano Med

• Website: oranomed.com
• Ownership type: Private
• Headquarters: Plano, Texas, United States (USA)
• Employee distribution: France 55%, United States (USA) 42%, Other 2%
• Founded year: 2009
• Headcount: 51-200
• LinkedIn: areva-med-llc

Orano Med, founded in 2009 and based in Plano, Texas, is a biotechnology firm dedicated to developing targeted therapies for cancer. The company specializes in utilizing lead-212, a rare alpha-emitting radioisotope, to create innovative treatments aimed at addressing significant unmet medical needs in oncology. Orano Med operates with a clear mission to make Targeted Alpha Therapy (TAT) a reality, focusing on the development of a robust pipeline of 212Pb-based therapies. They have established preclinical laboratories in both the United States and France, and are currently conducting two clinical trials. Their production platform for lead-212 ensures a reliable supply chain for their therapies, which is essential for advancing their clinical research and future commercial needs. Orano Med's strategic approach combines advanced chemistry and conjugation technology, allowing them to radiolabel lead-212 to various biological vectors targeting cancer cells. This positions them as a significant entity in the pharmaceutical manufacturing industry, particularly in the field of oncology.

8. DPT Laboratories

• Website: dptlabs.com
• Ownership type: Private Equity
• Headquarters: San Antonio, Texas, United States (USA)
• Employee distribution: United States (USA) 99%, Other 1%
• Latest funding: January 2025
• Founded year: 1938
• Headcount: 501-1000
• LinkedIn: dpt-laboratories

DPT Laboratories, founded in 1938 and based in San Antonio, Texas, operates as a contract development and manufacturing organization (CDMO) specializing in pharmaceutical services. The company offers a comprehensive suite of solutions that includes drug formulation, stability testing, and clinical trial supplies. DPT serves a variety of clients, primarily pharmaceutical companies and contract research organizations (CROs), facilitating the transition from product development to commercial manufacturing. Their expertise is particularly noted in semi-solid and liquid dosage forms, such as creams, gels, and aerosols. DPT is committed to maintaining high standards of quality and compliance, ensuring that all products meet the latest cGMP regulations. With a workforce of around 500 employees, DPT continues to invest in its capabilities to support the evolving needs of the pharmaceutical industry.

9. Neos Therapeutics, Inc.

• Website: neostx.com
• Ownership type: Corporate
• Headquarters: Grand Prairie, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $44.9M, December 2020
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: neos-therapeutics

Neos Therapeutics, Inc. is a pharmaceutical company based in Grand Prairie, Texas, established in 2008. The company specializes in innovative prescription therapeutics aimed at treating Attention Deficit Hyperactivity Disorder (ADHD) and addressing pediatric health needs. Neos Therapeutics is dedicated to developing and commercializing products that enhance patient wellness, with a strong focus on serving both consumers and healthcare providers. Their product portfolio includes central nervous system stimulants for ADHD and various pediatric health solutions, such as allergy treatments and fluoride supplements. The company operates with a patient-first philosophy, offering support programs designed to improve treatment accessibility and patient compliance. In December 2020, Neos Therapeutics secured $44.9 million in funding, reflecting their active engagement in the pharmaceutical sector and commitment to advancing their product pipeline.

10. Evestra, Inc.

• Website: evestra.com
• Ownership type: Private
• Headquarters: Schertz, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Convertible note, $1.8M, December 2009
• Founded year: 2020
• Headcount: 11-50
• LinkedIn: evestra-inc.

Evestra, Inc. is a private biopharmaceutical company based in Schertz, Texas, founded in 2020. The company specializes in innovative products aimed at improving women's health, focusing on areas such as fertility control, endometriosis, hormone replacement therapy, and oncology. Evestra employs advanced medicinal chemistry and drug delivery technologies to develop its product pipeline, which includes both pre-clinical and clinical-stage products. The company operates from two facilities in the San Antonio area, equipped for both research and development as well as Good Manufacturing Practice (GMP) manufacturing of active pharmaceutical ingredients (APIs) and drug products. Evestra has established partnerships with organizations like the Bill and Melinda Gates Foundation to enhance access to contraceptive methods in underserved regions. Their commitment to addressing significant health issues affecting women globally positions them as a notable entity in the pharmaceutical manufacturing industry.

11. Fagron US

• Website: fagron.us
• Ownership type: Private
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: United States (USA) 92%, Brazil 8%
• Founded year: 1980
• Headcount: 201-500
• LinkedIn: fagron-us

Fagron US, based in Austin, Texas, is a pharmaceutical compounding company founded in 1980. The company specializes in providing innovative compounding solutions and products tailored to the needs of pharmacists and pharmacies. Fagron US emphasizes personalized medication, aiming to enhance patient care through high-quality formulations and comprehensive educational resources. With a workforce of around 62 employees and a presence in over 30 countries, Fagron US operates a network of 70 facilities and collaborates with over 4,000 suppliers. Their product offerings include a wide range of active pharmaceutical ingredients (APIs) and proprietary formulations designed to meet the specific needs of healthcare providers. Fagron US is also involved in industry partnerships and educational initiatives, such as the Fagron Academy, which supports pharmacists in their compounding practices. The company has not reported any recent funding, indicating a stable operational model without external financial backing.

12. Peloton Therapeutics

• Website: pelotontherapeutics.com
• Ownership type: Corporate
• Headquarters: Dallas, Texas, United States (USA)
• Latest funding: May 2019
• Founded year: 2011
• Headcount: 11-50
• LinkedIn: peloton-therapeutics

Peloton Therapeutics, Inc. is a clinical stage pharmaceutical company based in Dallas, Texas, founded in 2011. The company is dedicated to developing innovative medicines aimed at treating cancer and other serious diseases. Peloton specializes in drug discovery, with a particular emphasis on HIF-2α, a transcription factor that has been challenging to target with small molecules. They have made significant strides in this area, being the first to bring a HIF-2α-targeting drug into clinical development. Their research efforts focus on identifying novel compounds that can effectively modulate complex protein-protein interactions involved in disease progression. Peloton's work has the potential to transform treatment paradigms for conditions such as kidney cancer and VHL Disease, ultimately improving patient outcomes. The company actively conducts clinical trials to advance their therapies and is engaged in partnerships to further their mission.

13. Vital Health Care Inc

• Website: vitalhealthcare.net
• Ownership type: Private
• Headquarters: Edinburg, Texas, United States (USA)
• Employee distribution: India 68%, United States (USA) 32%
• Founded year: 1999
• Headcount: 51-200
• LinkedIn: vital-health-care-inc

Vital Health Care Inc, founded in 1999, is a pharmaceutical manufacturer based in Edinburg, Texas. The company specializes in the production of active pharmaceutical ingredients (APIs), catering to both national and international pharmaceutical companies. Vital Health Care is particularly known for its high-quality Quinine products and a range of other medicinal compounds. The company operates two manufacturing facilities in India, which are equipped to meet stringent regulatory standards, including those set by WHO, EDQM, and USFDA. With a workforce that includes a significant percentage of employees in India, Vital Health Care has positioned itself as a reliable supplier in the global pharmaceutical market. Their ongoing research and development efforts aim to innovate and improve their product offerings, ensuring they meet the evolving needs of their clients. Vital Health Care has also achieved recognition as a 'STAR EXPORT HOUSE', indicating their strong presence in the export market, with a growing contribution from international sales.

14. Remus Pharmaceuticals Limited

• Website: remuspharma.com
• Ownership type: Private
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: India 97%, United States (USA) 3%
• Founded year: 2015
• Headcount: 201-500
• LinkedIn: remus-pharmaceuticals-pvt--ltd-

Remus Pharmaceuticals Limited, based in Austin, Texas, is a private pharmaceutical company that specializes in marketing innovative medicinal products and generic drugs. Founded in 2015, the company has quickly built a comprehensive portfolio that includes over 600 products across various therapeutic areas such as oncology, dermatology, cardiovascular health, and diabetes management. Remus Pharmaceuticals serves healthcare providers and pharmacies, ensuring access to effective and affordable medications. The company operates primarily through its manufacturing facilities in India and the USA, where it produces a wide range of dosage forms, including tablets, capsules, and injectables. With a strong focus on quality and regulatory compliance, Remus Pharmaceuticals is dedicated to meeting global healthcare demands and fulfilling unmet medical needs. Their commitment to research and development, along with a proficient regulatory team, enables them to navigate the complexities of the pharmaceutical industry effectively.

15. AustinPx

• Website: austinpx.com
• Ownership type: Private
• Headquarters: Georgetown, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $4.7M, October 2020
• Founded year: 2007
• Headcount: 51-200
• LinkedIn: austin-pharmaceutics

AustinPx, founded in 2007 and based in Georgetown, Texas, is a pharmaceutical development company that provides contract development and manufacturing services. The company specializes in enhancing drug bioavailability and offers formulation development to help pharmaceutical clients navigate the complexities of drug solubility and market readiness. AustinPx is known for its proprietary KinetiSol technology, which is a next-generation amorphous solid dispersion technology designed to improve the solubility of poorly soluble active pharmaceutical ingredients (APIs). This technology has been recognized for its innovative approach and has been applied to various challenging drug candidates. With a team of experts in formulation, analytical, and manufacturing processes, AustinPx supports clients from preclinical stages through to Phase II clinical trials. The company has also secured funding, indicating ongoing investment in its capabilities and growth within the pharmaceutical sector.

16. Opexa Therapeutics

• Website: opexatherapeutics.com
• Ownership type: Corporate
• Headquarters: The Woodlands, Texas, United States (USA)
• Employee distribution: United States (USA) 68%, India 32%
• Latest funding: September 2017
• Founded year: 1986
• Headcount: 11-50
• LinkedIn: opexa-therapeutics

Opexa Therapeutics, based in The Woodlands, Texas, is a biotechnology firm established in 1986. The company specializes in the development of personalized immunotherapies aimed at treating autoimmune diseases, with a particular focus on multiple sclerosis (MS) and neuromyelitis optica (NMO). Their flagship product, Tcelna®, is a personalized T-cell immunotherapy currently in Phase IIb clinical trials, specifically designed to cater to the unique immune response profiles of patients. Opexa also works on OPX-212, another autologous T-cell therapy targeting NMO. The company operates a cGMP manufacturing facility, which underscores its capabilities in producing therapies that meet stringent regulatory standards. Opexa's mission is to advance the field of Precision Immunotherapy, aligning the interests of patients, employees, and shareholders while striving to improve patient outcomes through innovative treatments.

17. Signature Biologics

• Website: signaturebiologics.com
• Ownership type: Private
• Headquarters: Irving, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2007
• Headcount: 11-50
• LinkedIn: signaturebiologics

Signature Biologics, founded in 2007 and based in Irving, Texas, is a biotechnology firm dedicated to the development and manufacturing of cellular therapeutics and biologics. The company operates a state-of-the-art facility that emphasizes innovative manufacturing techniques to produce high-quality human cellular products. Their mission is to enhance patient care through advanced therapeutic solutions, which they achieve by adhering to rigorous scientific and clinical standards. Signature Biologics is accredited by the American Association of Tissue Banks and follows current Good Manufacturing Practices (cGMP) and current Good Tissue Practices (cGTP), ensuring that their products meet the highest quality and safety standards. The leadership team, including experts in stem cell research and regenerative medicine, drives the company's vision to become a trusted source of cellular and biologic therapeutic solutions globally. With a commitment to research and development, Signature Biologics is positioned to make significant contributions to the regenerative medicine sector.

18. IsoTherapeutics

• Website: isotherapeutics.com
• Ownership type: Corporate
• Headquarters: Angleton, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $13.0M, February 2024
• Founded year: 2005
• Headcount: 11-50
• LinkedIn: isotherapeutics-group-llc

IsoTherapeutics, founded in 2005 and based in Angleton, Texas, is a company dedicated to the development of radiopharmaceuticals. With a team that boasts over 100 years of collective experience, they provide a range of services including radiochemistry, radiolabeling, and cGMP manufacturing tailored for clinical trials. Their facilities are equipped to support early-stage research and the transition of products to clinical trial manufacturing. IsoTherapeutics has collaborated with numerous pharmaceutical and biotechnology companies, aiding in the development of new therapeutic agents. The company has also received significant funding, with a reported amount of $13 million in early 2024, which underscores their growth and ongoing projects. Recently, they were acquired by Telix Pharmaceuticals, enhancing their capabilities and expanding their reach within the pharmaceutical industry.

19. Maxwell Biosciences

• Website: maxwellbiosciences.com
• Ownership type: Venture Capital
• Headquarters: Austin, Texas, United States (USA)
• Employee distribution: United States (USA) 75%, India 12%, Canada 12%
• Latest funding: January 2023
• Founded year: 2016
• Headcount: 11-50
• LinkedIn: maxwell-biosciences

Maxwell Biosciences, founded in 2016 and based in Austin, Texas, is a biotechnology firm dedicated to advancing synthetic immune system technologies. The company is focused on developing therapeutics to address infectious diseases, leveraging its proprietary Claromer® platform. This platform aims to create effective treatments for a range of pathogens, including those resistant to current antibiotics. Maxwell's research is rooted in a scientific foundation that includes collaborations with prestigious institutions such as Stanford University and the National Institutes of Health. The company is currently in the preclinical stage, with plans for human trials set for 2025. Their lead drug candidate, MXB-22,510, shows promise as a broad-spectrum therapeutic that could potentially replace many existing antifungals and antibiotics. Maxwell Biosciences is also recognized for its innovative approach to biodefense, making it a significant player in the pharmaceutical landscape.

20. Jurata Thin Film

• Website: juratatf.com
• Ownership type: Venture Capital
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Other (Grant), September 2023
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: jurata-thin-film

Jurata Thin Film is a biotechnology firm based in Houston, Texas, founded in 2019. The company specializes in developing innovative drug delivery systems aimed at improving the storage and administration of vaccines and biologics. Their unique technology allows for the long-term storage of therapeutic cargo at ambient or elevated temperatures, eliminating the need for cold chain logistics. This advancement is particularly significant in making vaccines more accessible globally. Jurata collaborates with healthcare providers and pharmaceutical organizations to enhance vaccine distribution, focusing on simplifying the manufacturing and delivery processes. The company has received attention for its work, including a recent grant from CEPI to develop under-the-tongue films for mRNA-LNP vaccine delivery, showcasing their commitment to advancing vaccine technology.

21. Scorpion Biological Services

• Website: scorpionbio.com
• Ownership type: Private
• Headquarters: San Antonio, Texas, United States (USA)
• Founded year: 2021
• Headcount: 11-50
• LinkedIn: scorpion-biological-services

Scorpion Biological Services, known as Scorpius BioManufacturing, is a biotechnology company based in San Antonio, Texas. Founded in 2021, the company specializes in contract development and manufacturing services for biologics. Scorpius offers a range of services including cGMP manufacturing, analytical testing, and process development, catering to the needs of pharmaceutical and biotech companies. Their facilities are equipped with American-made technology, emphasizing quality and compliance in biomanufacturing. Scorpius is dedicated to accelerating product development timelines, supporting clients from pre-clinical evaluation through to commercial manufacturing. Their operational focus includes mammalian cell culture and microbial fermentation, making them a valuable partner for companies looking to bring new therapies to market.

22. Tvardi Therapeutics

• Website: tvardi.com
• Ownership type: Private
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2017
• Headcount: 1-10
• LinkedIn: tvardi

Tvardi Therapeutics is a private, clinical-stage biopharmaceutical company based in Houston, Texas, founded in 2017. The company is dedicated to developing novel therapies aimed at treating cancer and fibrotic diseases. Its lead product, TTI-101, is an oral small molecule that inhibits STAT3, a protein implicated in tumor growth and fibrosis. Tvardi is currently conducting multiple clinical trials to evaluate the efficacy of TTI-101 in various cancer types and idiopathic pulmonary fibrosis (IPF). The company is staffed by a team of experienced professionals, including scientists and physicians, who are committed to addressing significant medical needs. Tvardi has been recognized as one of the promising biotechnology companies in the industry, highlighting its potential impact in the pharmaceutical sector.

23. ImmunoGenesis, Inc.

• Website: immunogenesis.com
• Ownership type: Venture Capital
• Headquarters: Houston, Texas, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: December 2020
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: immunogenesis-inc

ImmunoGenesis, Inc. is a biopharmaceutical company based in Houston, Texas, founded in 2019. The company specializes in immuno-oncology, focusing on developing innovative therapies for cold tumors, which are often resistant to existing treatments. Their lead products include IMGS-001, a dual-specific PD-L1/PD-L2 inhibitor, and IMGS-101, a hypoxia-reversal agent. These therapies aim to enhance treatment efficacy and improve patient outcomes for those diagnosed with cold tumors. ImmunoGenesis is currently engaged in clinical trials, with their lead candidate, IMGS-001, having recently dosed its first patient in a Phase 1a/1b trial. The company operates from JLABS @ TMC, a biotech incubator that provides essential resources for their research and development efforts. Their commitment to addressing the challenges posed by cold tumors positions them as a notable entity in the pharmaceutical manufacturing sector.

Pharmaceutical Manufacturing Insights: Key Companies in Texas

Want to Find More Pharmaceutical Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!